KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ionis Pharmaceuticals (IONS) EPS (Weighted Average and Diluted) (2016 - 2025)

Ionis Pharmaceuticals has reported EPS (Weighted Average and Diluted) over the past 17 years, most recently at -$1.41 for Q4 2025.

  • Quarterly results put EPS (Weighted Average and Diluted) at -$1.41 for Q4 2025, down 113.64% from a year ago — trailing twelve months through Dec 2025 was -$2.44 (up 19.74% YoY), and the annual figure for FY2025 was -$2.38, up 21.71%.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$1.41 at Ionis Pharmaceuticals, down from -$0.8 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for IONS hit a ceiling of $1.41 in Q4 2021 and a floor of -$1.41 in Q4 2025.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was -$0.62 (2021), compared with a mean of -$0.52.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): crashed 1000.0% in 2024 and later surged 255.56% in 2025.
  • Ionis Pharmaceuticals' EPS (Weighted Average and Diluted) stood at $1.41 in 2021, then crashed by 126.24% to -$0.37 in 2022, then skyrocketed by 83.78% to -$0.06 in 2023, then crashed by 1000.0% to -$0.66 in 2024, then tumbled by 113.64% to -$1.41 in 2025.
  • The last three reported values for EPS (Weighted Average and Diluted) were -$1.41 (Q4 2025), -$0.8 (Q3 2025), and $0.7 (Q2 2025) per Business Quant data.